Hi lakota6,
Yes it has been a disappointing last 4 weeks. I agree with you about the dilution of the of the SP and I'm curious as to the % Dr G is now holding. If he wants to maintain his position within the company of holding over %50 of all shares, then I would suggest that his accountant would be doing some mathematical equations to organise his Share Holdings. This would need to be precise considering he will miss out on his bonus options.
The CR & CN saga is doing damage to this SP and it is difficult to point the finger at any 1 organisation for the blame game. I'm not sure if the release of all those announcements last week was designed to cause massive confusion, or as GMV is renouned for, they were late at releasing them. Either way, we need to get this to bed and stop these bot's selling the SP down.
I still have complete confidence that GMV will be a competitive global player in the Health Sector and I look forward to the more productive and happier times down the road.
Cheers Rubes
- Forums
- ASX - By Stock
- GMV
- Ann: Completed Capital Raising
Ann: Completed Capital Raising, page-35
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online